Becoming fat

Genes and Development

Volumn 16, Issue 1, 2002, Pages 1-5

  Lazar, M A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THIAZOLIDINE DERIVATIVE; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ADIPOSE TISSUE CELL; AMINO TERMINAL SEQUENCE; ANIMAL MODEL; CALORIC INTAKE; CELL DIFFERENTIATION; DNA BINDING; FEEDBACK SYSTEM; GENE EXPRESSION; GENETIC VARIABILITY; LIFESTYLE; LIGAND BINDING; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SITTING;

ADIPOCYTES; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; OBESITY; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0036143008     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.964002     Document Type: Review

References (50)

1. Transcriptional activation by PPARγ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site
2. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
3. PPARγ, the ultimate thrifty gene
4. PPARγ is required for placental, cardiac, and adipose tissue development
5. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein
6. Activation of PPARγ leads to inhibition of anchorage independent growth of human colorectal cancer cells
7. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells
8. Peroxisome proliferator-activated receptor γ (PPARγ): Adipose predominant expression and induction early in adipocyte differentiation
9. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
10. A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
11. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members
12. PPARα and PPARγ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
13. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes
14. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
15. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ heterodimer. A basis for new therapeutic strategies
16. PPARγ3 mRNA: A distinct PPARγ mRNA subtype transcribed from an independent promoter
17. Ectopic expression of the CCAAT/enhancer binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells
18. Role of PPAR γ in regulating adipocyte differentiation and insulin-responsive glucose uptake
19. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ
20. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
21. Roles of PPARs in health and disease
22. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
23. Activation of the peroxisome proliferator activated receptor γ promotes the development of colon tumors in C57BL/6J-APCmin/+ mice
24. Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
25. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program
26. Modulating the transcriptional control of adipogenesis
27. McBindall - A better name for CCAAT/enhancer binding proteins?
28. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes
29. Life without fat: A transgenic mouse
30. PPAR γ and the treatment of insulin resistance
31. PPARγ knockdown by engineered transcription factors: Exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis
32. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
33. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
34. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro
35. C/EBPα induces adipogenesis through PPARγ: A unified pathway
36. Activators of the nuclear receptor PPARγ enhance colon polyp formation
37. Differentiation and reversal of malignant changes in colon cancer through PPARγ
38. Retinoic acid blocks adipogenesis by inhibiting C/EBPβ-mediated transcription
39. PPARγ, C/EBPα, cell cycle status and the commitment to adipocyte differentiation
40. Interdomain communication regulating PPARγ ligand binding
41. A novel therapy for colitis utilizing PPARγ ligands to inhibit the epithelial inflammatory response
42. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
43. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
44. Impaired energy homeostasis in C/EBPα knockout mice
45. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line
46. Ligand-independent activation domain in the N terminus of PPARγ. Differential activity of PPARγ1 and 2 isoforms and influence of insulin
47. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis
48. Cross-regulation of C/EBP α and PPAR γ controls the transcriptional pathway of adipogenesis and insulin sensitivity
49. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARγ
50. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins